Chloride Channel 7 (ClCN7) Gene Mutations and Autosomal Dominant Osteopetrosis, Type II-Reference-Cited by-同舟云学术

Chloride Channel 7 (ClCN7) Gene Mutations and Autosomal Dominant Osteopetrosis, Type II

Published:2003-08-01 Issue:8 Volume:18 Page:1513-1518
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Waguespack Steven G,Koller Daniel L,White Kenneth E,Fishburn Tonya,Carn Gwenaelle,Buckwalter Kenneth A,Johnson Michelle,Kocisko Maureen,Evans Wayne E,Foroud Tatiana,Econs Michael J

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference25 articles.

1. Osteopetrosis in adults;Hinkel;AJR Am J Roentgenol,1955

2. Serum creatine kinase isoenzyme BB in mammalian osteopetrosis;Bollerslev;Clin Orthop,2000

3. Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers;Waguespack;J Clin Endocrinol Metab,2002

4. Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form;Johnston;Medicine (Baltimore),1968

5. Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): Clinical and radiological manifestations in 42 patients;Bénichou;Bone,2000

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downregulation of Chloride voltage-gated channel 7 contributes to hyperalgesia following spared nerve injury;Journal of Biological Chemistry;2024-09

2. Gain-of-function variants in CLCN7 cause hypopigmentation and lysosomal storage disease;Journal of Biological Chemistry;2024-07

3. Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background;Calcified Tissue International;2024-05-11

4. Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study;The Journal of Clinical Endocrinology & Metabolism;2024-04-25

5. The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction;Calcified Tissue International;2024-03-14